| Trial ID: | L0989 |
| Source ID: | NCT01237119
|
| Associated Drug: |
Liraglutide
|
| Title: |
Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
|
| Acronym: |
LEAN
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: Liraglutide|Other: Liraglutide-placebo
|
| Outcome Measures: |
Liver Histological improvement|NAFLD Activity Score
|
| Sponsor/Collaborators: |
University of Birmingham|Wellcome Trust|Novo Nordisk A/S
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
52
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
August 2010
|
| Completion Date: |
July 2014
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 23, 2016
|
| Locations: |
NIHR BRU Centre for liver research, Queens Elizabeth University Hospital Birmingham, Birmingham, West Midlands, United Kingdom
|
| URL: |
https://ClinicalTrials.gov/show/NCT01237119
|
